Case Report
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Feb 15, 2020; 12(2): 237-247
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.237
Cryoablation combined with radiotherapy for hepatic malignancy: Five case reports
Yue-E Liu, Jie Zong, Xue-Ji Chen, Rui Zhang, Xiao-Cang Ren, Zhi-Jun Guo, Chao-Xing Liu, Qiang Lin
Yue-E Liu, Jie Zong, Xue-Ji Chen, Rui Zhang, Xiao-Cang Ren, Zhi-Jun Guo, Qiang Lin, Department of Oncology, North China Petroleum Bureau General Hospital, Hebei Medical University, Renqiu 062552, Hebei Province, China
Zhi-Jun Guo, Department of Radiology, North China Petroleum Bureau General Hospital, Hebei Medical University, Renqiu 062552, Hebei Province, China
Chao-Xing Liu, Department of Oncology, No.1 Hospital of Shijiazhuang City, Shijiazhuang 050000, China
Author contributions: Liu YE participated in the design of the subject and drafted the manuscript; Zong J, Chen XJ, Zhang R and Ren XC participated in the therapy for these five patients and the interpretation of data; Guo ZJ participated in the design of the subject and the interpretation of radiological data; Liu CX participated in the design of the subject and helped to the writing of the manuscript; Lin Q designed the subject and interpreted the data, who is responsible for the whole manuscript. All authors issued final approval for the version to be submitted.
Supported by Health Commission of Hebei Province, No. G2018068.
Informed consent statement: Consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the guidelines from the check list have been adopted in the preparation of this manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Qiang Lin, Professor, Department of Oncology, North China Petroleum Bureau General Hospital, Hebei Medical University, 8 Huizhan Avenue, Renqiu 062552, Hebei Province, China. zyy_lq@petrochina.com.cn
Received: May 21, 2019
Peer-review started: May 21, 2019
First decision: September 20, 2019
Revised: October 28, 2019
Accepted: December 13, 2019
Article in press: December 13, 2019
Published online: February 15, 2020
Processing time: 271 Days and 1.6 Hours
Core Tip

Core tip: The therapeutic efficacy of monotherapy for primary hepatocellular carcinoma (HCC) and secondary HCC is usually poor, and thus, combination therapy is needed. A treatment plan of cryoablation combined with radiotherapy is safe and effective and may result in survival benefits to patients.